EMA reminds physicians to use Tecentriq with nab-paclitaxel for treating breast cancer

View source ↗

Summary

EMA reminds physicians to use Tecentriq (atezolizumab) in combination with nab-paclitaxel for treating certain breast cancer indications, highlighting approved …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• Tecentriq (atezolizumab)